Correlation Between Purple Biotech and Lineage Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Lineage Cell Therapeutics, you can compare the effects of market volatilities on Purple Biotech and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Lineage Cell.

Diversification Opportunities for Purple Biotech and Lineage Cell

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Purple and Lineage is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Lineage Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therapeutics and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therapeutics has no effect on the direction of Purple Biotech i.e., Purple Biotech and Lineage Cell go up and down completely randomly.

Pair Corralation between Purple Biotech and Lineage Cell

Assuming the 90 days trading horizon Purple Biotech is expected to under-perform the Lineage Cell. In addition to that, Purple Biotech is 1.21 times more volatile than Lineage Cell Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Lineage Cell Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest  47,190  in Lineage Cell Therapeutics on September 3, 2024 and sell it today you would lose (25,900) from holding Lineage Cell Therapeutics or give up 54.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Purple Biotech  vs.  Lineage Cell Therapeutics

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Lineage Cell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lineage Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Purple Biotech and Lineage Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and Lineage Cell

The main advantage of trading using opposite Purple Biotech and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.
The idea behind Purple Biotech and Lineage Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world